UK based pharmaceutical developer Futura Medical's licensing partner Reckitt Benckiser has received the CE mark for novel condom, CSD500.
Subscribe to our email newsletter
Following the CE mark, CSD500 has got license to be marketed in 29 European countries and also in a number of non-European territories.
Futura chief executive James Barder said they look forward to working with Reckitt Benckiser to commercialise CSD500.
Reckitt Benckiser spokesperson said they are evaluating plans to launch a product with CSD500 in the near future.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.